Published April 27, 2018
| Version v1
Dataset
Open
The process of HDAC11 Assay Development: time-course study follow-up
Authors/Creators
- 1. Structural Genomics Consortium/University of Toronto
Description
The time of incubation and conc. of the developer to be used are important parameters during HDAC11 assay optimization and thus, have been considered here.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
27april2018-HDAC11 assay deve process-time course followup.pdf
Files
(174.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c744051da19144a97749af66307162e2
|
174.5 kB | Preview Download |